Hosting a CAREWare Network
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/17/2023
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource updated 03/09/2023
Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource from the RWHAP Best Practices Compilation updated on 04/15/2024
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Session on a rural clinic's work and adjustments during COVID-19. Presentation from the Division of Community HIV/AIDS Programs (DCHAP) Business Day Meeting held at the 2022 National Ryan White Conference.
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 06/21/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Significant challenges exist in vaccinating people with HIV for COVID-19. Our RWPC program set out to implement and evaluate a vaccine initiative for COVID-19 for people with HIV. We achieved vaccine rates of 78 percent being fully vaccinated by December 1, 2021 and 30 percent having a third dose.
Resource (Conference Presentation) updated 09/14/2023
Review of rapid ART features to reduce time to ART from 7 to 1.6 days, including pre-visit benefits navigation, manufacturer discount cards, prescribing to in-house pharmacies, email distribution lists, and post-prescriptive follow-up.
Resource (Conference Presentation) updated 09/14/2023
Review of a 12-month clinical telePrEP program for rural South Carolina residents, which evaluated the feasibility and acceptability of PrEP delivered through a telehealth model.
Resource (Conference Presentation) updated 09/14/2023